Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-15

Clinical Trial Update: A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial comparing ferumoxytol with iron sucrose for iron deficiency anemia in adults with chronic kidney disease has completed with results posted in 2018…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FERUMOXYTOL (ferumoxytol)
  • Iron sucrose (iron sucrose)

Snippet

Sponsor: AMAG Pharmaceuticals, Inc. | Conditions: Iron Deficiency, Anemia | Phase 2 | Status: COMPLETED | Results posted: 2018-05-15